ALLIANCEBERNSTEIN HOLDING L.P.
No SEC Form 4 filings for $AB in the last 30 days.
See all $AB insider activity →AllianceBernstein (NYSE: AB) will release its Q3 2026 results on October 27, 2026, before market open. A conference call is scheduled for 9:00 a.m. CT. As of June 30, 2026, Equitable Holdings owns 68.1% of AB.
AllianceBernstein (AB) named Onur Erzan as its next CEO, effective April 1, 2027. Erzan, currently president, succeeds Seth Bernstein, who retires but remains on AB's board. AB's assets under management are $919 billion, with $169 billion in private wealth. Erzan joined AB in 2021 from McKinsey and has led key initiatives. AB is a subsidiary of Equitable Holdings.
ALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Ioanis Jorgali, Investors 629-213-6139 Ioanis.Jorgali@alliancerbernstein.com Carly Symington, Media (US) 615.417.5701 Carly.Symington@alliancerbernstein.com AllianceBernstein appoints Onur Erzan President & Chief Executive Officer Seth Bernstein to retire as Chief Executive Offic
Over the past 7 days, AlphAI's AI scored 1 news story mentioning AB (ALLIANCEBERNSTEIN HOLDING L.P.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent AB coverage spans earnings, financial news and corporate actions.
The announcement sets the market expectation for a forthcoming earnings report, likely prompting modest pre‑market positioning.
Leadership transition may affect strategic direction and investor sentiment.
Leadership transition may affect strategic direction and investor sentiment, but no immediate price impact expected.
AUM ticked up modestly on net inflows, with channel mix shifting toward Institutions and away from Retail.
The raise extends runway and reduces near-term financing risk while advancing two clinical programs, supporting risk-on positioning but dilutive overhang remains.
AlphAI scores every news story that mentions AB with an AI model for sentiment and relevance, and aggregates insider trades from ALLIANCEBERNSTEIN HOLDING L.P.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
AllianceBernstein (NYSE: AB) will release its Q3 2026 results on October 27, 2026, before market open. A conference call is scheduled for 9:00 a.m. CT. As of June 30, 2026, Equitable Holdings owns 68.1% of AB.
1 min readAllianceBernstein (AB) named Onur Erzan as its next CEO, effective April 1, 2027. Erzan, currently president, succeeds Seth Bernstein, who retires but remains on AB's board. AB's assets under management are $919 billion, with $169 billion in private wealth. Erzan joined AB in 2021 from McKinsey and has led key initiatives. AB is a subsidiary of Equitable Holdings.
2 min readALLIANCEBERNSTEIN HOLDING L.P. (AB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Ioanis Jorgali, Investors 629-213-6139 Ioanis.Jorgali@alliancerbernstein.com Carly Symington, Media (US) 615.417.5701 Carly.Symington@alliancerbernstein.com AllianceBernstein appoints Onur Erzan President & Chief Executive Officer Seth Bernstein to retire as Chief Executive Offic
2 min readAllianceBernstein (NYSE: AB) reported preliminary assets under management of $909 billion as of July 31, 2026, up from $906 billion at June 30. The firm cited firmwide net inflows despite unfavorable markets. Institutions saw strong inflows tied to a previously announced $12 billion commercial mortgage loans mandate, Private Wealth had modest inflows, and Retail had outflows.
3 min readAB Science (Euronext Paris: AB) raised EUR 14.2m via a private placement to fund early steps of a strategic plan due in September. The issue created 23.28m new shares; an existing long-term investor provided EUR 12m. Proceeds target AB8939 in AML and masitinib Phase III in ALS. Cash is about EUR 23m, covering needs beyond 12 months.
4 min readStonehill Charles G.T. sold 5,000 shares of ALLIANCEBERNSTEIN HOLDING L.P. (AB) at $37.17 ($0.19M total) on 2026-08-04.
1 min readStrategic Execution and Platform Scaling Achieved record AUM of $905 billion, driven by a return to positive organic growth and the strongest gross sales quarter in five years. Reached the $90 billion to $100 billion private markets AUM target more than a year ahead of schedule, validating a multi-year investment strategy in corporate lending and real estate debt.
6 min readAllianceBernstein Holding LP (AB) reported Q2 net income of $71.7 million, or 77 cents per share. Adjusted earnings were 82 cents per share. Revenue was $1.17 billion, with adjusted revenue of $887.5 million. The article notes AB shares down 1.5% YTD and 12% over 12 months.
1 min readAllianceBernstein (NYSE:AB) reported Q2 flows and earnings-call updates. Alternatives and multi-asset strategies drew over $4B net inflows, while active-equity outflows neared $11B and taxable fixed-income outflows exceeded $4B. Retail gross sales were $31B, yielding $900M net inflows. Private-market AUM rose to $91B. The firm raised 2026 performance-fee outlook to $115M-$135M and cut non-compensation expense guidance to $620M-$640M.
7 min readAdvanced Bionics, a Sonova brand, said the US FDA approved expanded indications for its cochlear implant systems for single-sided deafness (SSD) and asymmetric hearing loss (AHL). The criteria broaden adult and pediatric eligibility, with company-cited research estimating 271,000 to 345,000 US adults with SSD and only 2.1% using CIs among eligible patients.
3 min read
